Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia

Por Chen, Lei, Ascher-Svanum, Haya, Lawson, Anthony, Stauffer, Virginia L, Nyhuis, Allen, Haynes, Virginia, Schuh, Kory, Kinon, Bruce J
Publicado em 2013

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia

Por Ascher-Svanum, Haya, Brnabic, Alan JM, Lawson, Anthony H, Kinon, Bruce J, Stauffer, Virginia L, Feldman, Peter D, Kelin, Katarina
Publicado em 2012

Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States

Por Furiak, Nicolas M, Ascher-Svanum, Haya, Klein, Robert W, Smolen, Lee J, Lawson, Anthony H, Conley, Robert R, Culler, Steven D
Publicado em 2009

Evaluation of the Reliability of Electronic Medical Record Data in Identifying Comorbid Conditions among...

Por Muehlenbein, Catherine E., Hoverman, J. Russell, Gruschkus, Stephen K., Forsyth, Michael, Chen, Clara, Lopez, William, Lawson, Anthony, Hartnett, Heather J., Pohl, Gerhardt
Publicado em 2011

Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia

Por Stauffer Virginia L, Lawson Anthony H, Nyhuis Allen W, Detke Holland C, Zhao Fangyi, Ascher-Svanum Haya, Montgomery William, Witte Michael M, McDonnell David P
Publicado em 2011-09-01

Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia

Por Ascher-Svanum, Haya, Zhao, Fangyi, Detke, Holland C, Nyhuis, Allen W, Lawson, Anthony H, Stauffer, Virginia L, Montgomery, William, Witte, Michael M, McDonnell, David P
Publicado em 2011